Dr Stuart Hannah presents the sensor that could speed up the detection of...
Dr Stuart Hannah presents the sensor that could speed up the detection of antibiotic resistance considerably

Image source: University of Strathclyde

MRSA & Co.

Test to detect antibiotic resistance in less than 45 minutes

Scientists from Scotland are developing a low cost, rapid diagnostic sensor test which aims to show the susceptibility of bacteria to antibiotics within 45 minutes.

Laboratory testing of samples can take up to two days and the new test aims to allow doctors to be able to prescribe the correct antibiotic to a patient for an infection more quickly. In a research paper published in the journal Biosensors and Bioelectronics, the University of Strathclyde team has demonstrated the system is capable of showing results in less than 45 minutes. 

The scientists examined the difference in growth profiles between the common hospital acquired bacterial infections, Staphylococcus aureus, most strains of which are sensitive to antibiotics, and the drug resistant strain, MRSA, which is resistant to several widely used antibiotics and can be harder to treat. Both strains were placed onto electrodes covered in a special hydrogel deposit which monitored bacterial growth and which also contained antibiotics.

Results showed that the susceptible strain can grow on electrodes modified with gel containing no antibiotic, but could not grow when the sensor was seeded with antibiotic. However, due to its antibiotic resistance, the MRSA strain was still able to grow on the electrodes which contained clinically relevant concentrations of antibiotics.

Photo
Dr Stuart Hannah conducting a test in the laboratory
Source: University of Strathclyde

The paper’s lead author, Dr Stuart Hannah, said: “There is a small difference between what makes an organism susceptible to an antibiotic and what makes it resistant. In real terms, we were able to distinguish between the two strains in less than 45 minutes, which is a significant improvement on the current gold standard of up to two days. The technology uses a low cost, commercially available sensor which acts like a mini culture dish that can deal with any kind of clinical sample. The system is modified with a special gel deposit so that we can identify the difference between susceptible and resistant forms of common bacteria. Rapid result detection means you could pinpoint bacterial versus viral infections straight away and would be able to start working on the correct treatment more quickly for patients, which is very important for particular infections. Antibiotic resistance is less likely to develop if you give a narrower spectrum antibiotic.”

Recommended article

Photo

New data

WHO: High levels of antibiotic resistance found worldwide

WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries. WHO’s new Global Antimicrobial Surveillance System (GLASS) reveals widespread occurrence of antibiotic resistance among 500 000 people with suspected bacterial infections across 22 countries.

Antimicrobial resistance (AMR) – the ability of microorganisms like bacteria and fungi to grow in the presence of common antibiotics – is an increasing problem. According to a report released earlier this year by the United Nations and global health agencies, it could result in 10 million deaths worldwide each year by 2050 and damage to the economy as ‘catastrophic’ as the 2008-2009 global financial crisis. The National Institute for Health and Care Excellence (NICE) says AMR poses a ‘significant threat’ to public health. To tackle it effectively, better diagnostic testing and new technologies which can speedily assess the effectiveness for antibiotics and which one to prescribe, are needed.

A future device could be used at a GPs’ surgery, where they could effectively take a blood sample and do the test and have results within the hour, rather than sending samples to a laboratory and have to wait for a positive result

Stuart Hannah

The consultant anaesthetist on the project, Dr David Alcorn from Paisley’s Royal Alexandra Hospital, said: “Being able to quickly diagnose an infection is a great enough ability, but to be able to also detect AMR within such a short period of time could prove to be a wonderful tool. It means that vital diagnostic information could be provided for clinicians across intensive care units, operating theatres, and emergency departments, to enable them to give the right drug at the right time. There is also scope for this to have an enormous impact within general practice and day-to-day healthcare.”

The researchers hope that if the test is developed for commercial use, it could be used by pharmacists and other points of care. Dr Hannah added: "With the right commercial backing, a future device could be used at a GPs’ surgery, where they could effectively take a blood sample and do the test and have results within the hour, rather than sending samples to a laboratory and have to wait for a positive result. It could also have a place on intensive care wards. The first time someone is ill they are quite rightly given a broad spectrum antibiotic and also they have to wait for 12–72 hours for a result from the hospital laboratory. We would hope that the test can be located at the bedside and that it will allow doctors to switch from a broad spectrum agent to the right drug quite quickly.”

The next steps include developing the technology from a bespoke University laboratory approach into a generic prototype which can be tested in clinical settings with real patient samples. The University of Strathclyde has backed the work by filing an initial patent and efforts are now being made to find routes to commercialisation. Dr Hannah added: “Everything we are using can be mass manufactured which means that it is cheap to produce a working test.“


Source: University of Strathclyde

25.10.2019

Read all latest stories

Related articles

Photo

Epidemiology & economics

Bacterial resistance costs French hospitals up to 290 million Euros per year

A team of researchers from Versailles Saint-Quentin-en-Yvelines University (UVSQ), Inserm and Pasteur Institute (Unité Mixte de Recherche 1181 Biostatistique, biomathématique,…

Photo

MRSA

Decolonization protocol can prevent dangerous infections

Antiseptic soap, mouthwash, and nose ointment after hospital discharge reduced infections and infection-associated hospitalizations due to MRSA in high-risk patients. Hospital patients who have…

Photo

Antibiotic resistance

Killer bugs put on the critical list

While new agents to fight virulent pathogens are in the pipeline, a new study pinpoints where a recent addition is already being applied in the clinic.

Related products

Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

LIS, Middleware, POCT

Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

Siemens Healthineers